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We read with interest the paper by Sungar and Güven [1],
which described a case series of organophosphorus
pesticide (OP)-poisoned patients managed in their intensive
care unit. It clearly demonstrates the difficulty in managing
such patients in resource-poor areas [2]. However, we
should like to query some issues in their management of OP
poisoning and their use of pralidoxime.
We cannot understand their assessment of risk–benefit in the
use of atropine. Their regimen of 0.02–0.08 mg/kg atropine
as an infusion over 1 hour would provide a maximum of
5.6 mg atropine in a 70 kg person. Stopping atropine therapy
‘24 hours after atropinization’ may cause problems with the
continued release of fat-soluble OPs, such as fenthion, from
the fat depot. Those authors also do not state the time it took
for atropinization to be achieved; however, if patients received
atropine for a mean of ‘3.4 ± 2.1 days’, then the mean time to
atropinization was 2.4 ± 2.1 days. This appears far too long.
Few clinical toxicologists would disagree that full and early
atropinization with 2 mg atropine stat followed by 2 mg every
5–15 min has few risks and obvious benefits [3].
Their use of intravenous diltiazem or propranolol for
tachydysrhythmias associated with OP poisoning is troubling.
Hypotension and cardiac dysrhythmias are significant
problems in OP poisoning [3]. Do the authors have any
evidence that the benefits of these negative inotropic drugs
outweigh the risks in such patients?
The authors state that only one randomized controlled trial
(RCT) has been carried out that assessed the efficacy of
pralidoxime in OP poisoning. Unfortunately, the cited paper
was a retrospective case series that compared the case
fatality rate during a time when pralidoxime was not available
in Sri Lanka with the rate at a time when it was, and as such
is not a RCT [4].
We recently completed a systematic review of RCTs of
pralidoxime that identified two small RCTs and two very small
prospective studies [4]. The RCTs were carried out in
Vellore, India, and assessed the value of 12 g pralidoxime
given in an infusion over 3–4 days versus a 1 g bolus or
placebo. The trials failed to show any benefit. However,
recent World Health Organization guidelines [5] recommend
far higher doses – at least 30 mg/kg bolus followed by an
infusion of 8 mg/kg per hour. In practice, this becomes 2 g
stat followed by 500 mg/h – a dose far higher than that used
in the study of Sungur and Güven [1].
The authors also state that pralidoxime should not be used
longer than 48 hours after ingestion. This may not be true for
diethyl OPs. The time at which oxime administration is no
longer useful depends on the rate of acetylcholinesterase
ageing. In vitro, this occurs with a half-life of around 3 hours
for dimethyl OPs and 33 hours for diethyl OPs. Taking four
half-lives to be the latest that oximes can be effective, oximes
may be useful for diethyl compounds when started up to
120 hours after ingestion [4,5].
Finally, we agree with Sungar and Güven that further controlled
trials are required. We are now carrying out a large RCT in Sri
Lanka in 1500 patients to test the efficacy of the dose of
pralidoxime recommended by the World Health Organization.
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